Zhou Hui, Qiu Li-peng, Yan Xiao-xiao, Li Lin, Li Xiang, Wang Lu, Liu Mei, Wang Dong-kai
First Affiliated Hospital of China Medical University, Shenyang 110016, China.
Yao Xue Xue Bao. 2010 Sep;45(9):1177-82.
Oxaliplatin-loaded nanostuctured lipid carriers (OP-NLC) were prepared by ultrasonic emulsification method. And its optimal prescription was selected by orthogonal design. The laser light scattering technique, zeta potential analyzer, TEM, DSC, XRD and HPLC were employed to study the physicochemical parameters of OP-NLC, which displayed in terms of particle size, zeta potential, crystalline, drug loading and encapsulation efficiency. The results showed that OP-NLC had an average diameter of (111 +/- 20) nm, zeta potential of (-27.4 +/- 13.1) mV, encapsulation efficiency of (77.4 +/- 2.5) % and drug content of (0.8 +/- 1.5) mg mL(-1). TEM, DSC and XRD indicated that OP-NLC was spherical and the drug was dispersed as nanoparticles by means of non-crystalline. The in vitro release test showed that the drug could be sustained-released from NLC in buffer solution (pH 4.5) after a burst release in initial phase.
采用超声乳化法制备了载奥沙利铂的纳米结构脂质载体(OP-NLC)。并通过正交设计筛选出其最佳处方。采用激光散射技术、zeta电位分析仪、透射电子显微镜(TEM)、差示扫描量热法(DSC)、X射线衍射法(XRD)和高效液相色谱法(HPLC)研究OP-NLC的理化参数,包括粒径、zeta电位、晶型、载药量和包封率。结果表明,OP-NLC的平均直径为(111±20)nm,zeta电位为(-27.4±13.1)mV,包封率为(77.4±2.5)%,药物含量为(0.8±1.5)mg mL-1。TEM、DSC和XRD表明,OP-NLC呈球形,药物以非晶态形式分散为纳米颗粒。体外释放试验表明,药物在初始阶段有一个突释后,可在缓冲溶液(pH 4.5)中从NLC中持续释放。